Item

Synergistic effects of thyroid hormone receptor beta with selective agonist GC-1 and bromodomain inhibitors in ATC

Orsmond, Ian
Citations
Altmetric:
License
License
DOI
Abstract
Anaplastic thyroid cancer (ATC) is the fastest-growing cancer worldwide, with no treatment. ATC typically has an abnormal chromatin environment that alters gene expression. Thyroid hormone receptor beta (TRß) is a nuclear transcription factor and an ATC tumor suppressor. TRß activates bromodomain-containing proteins (BRDs), which open and close DNA to transcriptional machinery. The altered DNA structures mollify the cancer. Amplifying the effect of TRß on BRDs should suppress ATC powerfully. Our research will quantify the impact of select bromodomain inhibitors on an aggressive thyroid cancer phenotype. We will determine if the bromodomain inhibitors work synergistically with TRß agonism to combat ATC.
Description
Graduate
Date
2025-06-02
Journal Title
Journal ISSN
Volume Title
Publisher
Collections
UVM Student Research Conference
Show all metadata
Research Projects
Organizational Units
Journal Issue
Citation
URI
https://hdl.handle.net/20.500.14849/8957
DOI
Embedded videos